[96a5a0]: / output / allTrials / identified / NCT00975182_identified.json

Download this file

511 lines (511 with data), 21.7 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
{
"info": {
"nct_id": "NCT00975182",
"official_title": "A Phase Ib, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors",
"inclusion_criteria": "* Documented locally advanced or metastatic solid tumors for which standard therapy either does not exist or has proven ineffective or intolerable (dose-escalation stage only)\n* Documented locally advanced or metastatic NSCLC in patients who have failed at least one prior chemotherapy-based regimen for incurable disease (cohort-expansion stage only)\n* Adequate organ function as assessed by laboratory tests\n* Evaluable disease or disease measurable per Response Evaluation Criteria in Solid Tumors (RECIST)\n* Agreement to use an effective form of contraception for the duration of the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Any anti-cancer therapy (e.g., chemotherapy, biologic therapy, or hormonal therapy) within a specified timeframe prior to first study treatment\n* Prior treatment with PI3K pathway-inhibiting agents (cohort-expansion stage only)\n* History of Grade >= 3 fasting hyperglycemia or diabetes requiring regular medication\n* Current clinically significant and uncontrolled systemic disease (e.g., cardiovascular, pulmonary, or metabolic)\n* History of clinically significant cardiac or pulmonary dysfunction\n* History of malabsorption syndrome or other condition that would interfere with enteral absorption\n* Clinically significant history of liver disease\n* Any condition requiring full-dose anticoagulants, such as warfarin, heparin, or thrombolytic agents\n* Active autoimmune disease and/or need for corticosteroid therapy\n* Known brain metastases that are untreated, symptomatic, or require therapy\n* Pregnancy, lactation, or breastfeeding",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Documented locally advanced or metastatic solid tumors for which standard therapy either does not exist or has proven ineffective or intolerable (dose-escalation stage only)",
"criterions": [
{
"exact_snippets": "Documented locally advanced or metastatic solid tumors",
"criterion": "solid tumors",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
},
{
"exact_snippets": "standard therapy either does not exist or has proven ineffective or intolerable",
"criterion": "standard therapy",
"requirements": [
{
"requirement_type": "existence",
"expected_value": false
},
{
"requirement_type": "effectiveness",
"expected_value": false
},
{
"requirement_type": "tolerability",
"expected_value": false
}
]
}
]
},
{
"line": "* Documented locally advanced or metastatic NSCLC in patients who have failed at least one prior chemotherapy-based regimen for incurable disease (cohort-expansion stage only)",
"criterions": [
{
"exact_snippets": "Documented locally advanced or metastatic NSCLC",
"criterion": "NSCLC",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
},
{
"exact_snippets": "patients who have failed at least one prior chemotherapy-based regimen for incurable disease",
"criterion": "prior chemotherapy-based regimen",
"requirements": [
{
"requirement_type": "outcome",
"expected_value": "failed"
},
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "regimen"
}
}
]
}
]
},
{
"line": "* Adequate organ function as assessed by laboratory tests",
"criterions": [
{
"exact_snippets": "Adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "assessed by laboratory tests",
"criterion": "laboratory tests",
"requirements": [
{
"requirement_type": "assessment method",
"expected_value": "laboratory tests"
}
]
}
]
},
{
"line": "* Evaluable disease or disease measurable per Response Evaluation Criteria in Solid Tumors (RECIST)",
"criterions": [
{
"exact_snippets": "Evaluable disease",
"criterion": "disease",
"requirements": [
{
"requirement_type": "evaluability",
"expected_value": true
}
]
},
{
"exact_snippets": "disease measurable per Response Evaluation Criteria in Solid Tumors (RECIST)",
"criterion": "disease",
"requirements": [
{
"requirement_type": "measurability",
"expected_value": "per Response Evaluation Criteria in Solid Tumors (RECIST)"
}
]
}
]
},
{
"line": "* Agreement to use an effective form of contraception for the duration of the study",
"criterions": [
{
"exact_snippets": "Agreement to use an effective form of contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
},
{
"requirement_type": "duration",
"expected_value": "for the duration of the study"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Any anti-cancer therapy (e.g., chemotherapy, biologic therapy, or hormonal therapy) within a specified timeframe prior to first study treatment",
"criterions": [
{
"exact_snippets": "Any anti-cancer therapy (e.g., chemotherapy, biologic therapy, or hormonal therapy) within a specified timeframe prior to first study treatment",
"criterion": "anti-cancer therapy",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": "within a specified timeframe prior to first study treatment"
}
]
}
]
},
{
"line": "* Prior treatment with PI3K pathway-inhibiting agents (cohort-expansion stage only)",
"criterions": [
{
"exact_snippets": "Prior treatment with PI3K pathway-inhibiting agents",
"criterion": "prior treatment with PI3K pathway-inhibiting agents",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* History of Grade >= 3 fasting hyperglycemia or diabetes requiring regular medication",
"criterions": [
{
"exact_snippets": "History of Grade >= 3 fasting hyperglycemia",
"criterion": "fasting hyperglycemia",
"requirements": [
{
"requirement_type": "grade",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "N/A"
}
},
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "diabetes requiring regular medication",
"criterion": "diabetes",
"requirements": [
{
"requirement_type": "medication requirement",
"expected_value": true
}
]
}
]
},
{
"line": "* Current clinically significant and uncontrolled systemic disease (e.g., cardiovascular, pulmonary, or metabolic)",
"criterions": [
{
"exact_snippets": "clinically significant and uncontrolled systemic disease",
"criterion": "systemic disease",
"requirements": [
{
"requirement_type": "significance",
"expected_value": "clinically significant"
},
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "cardiovascular",
"criterion": "cardiovascular disease",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "pulmonary",
"criterion": "pulmonary disease",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "metabolic",
"criterion": "metabolic disease",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
}
]
},
{
"line": "* History of clinically significant cardiac or pulmonary dysfunction",
"criterions": [
{
"exact_snippets": "History of clinically significant cardiac ... dysfunction",
"criterion": "cardiac dysfunction",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "History of clinically significant ... pulmonary dysfunction",
"criterion": "pulmonary dysfunction",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
}
]
},
{
"line": "* History of malabsorption syndrome or other condition that would interfere with enteral absorption",
"criterions": [
{
"exact_snippets": "History of malabsorption syndrome",
"criterion": "malabsorption syndrome",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "other condition that would interfere with enteral absorption",
"criterion": "condition interfering with enteral absorption",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Clinically significant history of liver disease",
"criterions": [
{
"exact_snippets": "Clinically significant history of liver disease",
"criterion": "liver disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": "clinically significant"
}
]
}
]
},
{
"line": "* Any condition requiring full-dose anticoagulants, such as warfarin, heparin, or thrombolytic agents",
"criterions": [
{
"exact_snippets": "Any condition requiring full-dose anticoagulants",
"criterion": "condition requiring full-dose anticoagulants",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "such as warfarin, heparin, or thrombolytic agents",
"criterion": "use of anticoagulants",
"requirements": [
{
"requirement_type": "specific drugs",
"expected_value": [
"warfarin",
"heparin",
"thrombolytic agents"
]
}
]
}
]
},
{
"line": "* Active autoimmune disease and/or need for corticosteroid therapy",
"criterions": [
{
"exact_snippets": "Active autoimmune disease",
"criterion": "autoimmune disease",
"requirements": [
{
"requirement_type": "activity",
"expected_value": true
}
]
},
{
"exact_snippets": "need for corticosteroid therapy",
"criterion": "corticosteroid therapy",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* Known brain metastases that are untreated, symptomatic, or require therapy",
"criterions": [
{
"exact_snippets": "Known brain metastases",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "untreated",
"criterion": "brain metastases treatment status",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "untreated"
}
]
},
{
"exact_snippets": "symptomatic",
"criterion": "brain metastases symptoms",
"requirements": [
{
"requirement_type": "symptoms",
"expected_value": true
}
]
},
{
"exact_snippets": "require therapy",
"criterion": "brain metastases therapy requirement",
"requirements": [
{
"requirement_type": "therapy requirement",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnancy, lactation, or breastfeeding",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "lactation",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breastfeeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}